← Leaderboards
Andrew Edward Blum
Louis Stokes Cleveland Va Medical Center
$1,203,936
Attributed
$1,203,936
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $408.1K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,203,936 · 1
VA$0 · 1
By mechanism
P01$1,203,936 · 1
IK2$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Lesion”
- Paula Gonzalez-Maya · Fundacion Inciensa$17,061,460
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- Thomas Dick · Rbhs-New Jersey Medical School$10,715,746
- J. Silvio Gutkind · University Of California, San Diego$8,475,093
- Gabriel Nestor Sanchez · Enspectra Health, Inc.$7,941,485
- Vikram Khurana · Brigham And Women'S Hospital$6,679,723
Research focus
LesionPathway InteractionsDysplasiaIn VivoMolecularOrganoidsDesignDistalEsophagusIntestinesMalignant NeoplasmsMediatingNeoplasmsMucous MembraneBarrett EsophagusCellsBiopsy3-DimensionalBindingEsophageal AdenocarcinomaGastroenterologyGenome-WideCell LinePrograms
Grant awards (8)
EPHB2-Dependent Signaling: A New Molecular Paradigm in Barrett's Neoplasia$408,114
P01 · FY2025 · CA · contact PI
EPHB2-Dependent Signaling: A New Molecular Paradigm in Barrett's Neoplasia$387,708
P01 · FY2024 · CA · contact PI
TGFβ and Smad Signaling Components in Esophageal Adenocarcinoma$0
IK2 · FY2024 · VA · contact PI
EPHB2-Dependent Signaling: A New Molecular Paradigm in Barrett's Neoplasia$408,114
P01 · FY2023 · CA · contact PI
TGFβ and Smad Signaling Components in Esophageal Adenocarcinoma$0
IK2 · FY2023 · VA · contact PI
TGFβ and Smad Signaling Components in Esophageal Adenocarcinoma$0
IK2 · FY2022 · VA · contact PI
TGFβ and Smad Signaling Components in Esophageal Adenocarcinoma$0
IK2 · FY2021 · VA · contact PI
TGFβ and Smad Signaling Components in Esophageal Adenocarcinoma$0
IK2 · FY2020 · VA · contact PI